Yehuda Handelsman to Hyperlipidemias
This is a "connection" page, showing publications Yehuda Handelsman has written about Hyperlipidemias.
Connection Strength
0.729
-
Lipid-lowering efficacy and safety of alirocumab in patients with or without diabetes: A sub-analysis of ODYSSEY COMBO II. Diabetes Obes Metab. 2017 07; 19(7):989-996.
Score: 0.543
-
Clinical effects of colesevelam in Hispanic subjects with primary hyperlipidemia and prediabetes. Postgrad Med. 2012 Jul; 124(4):14-20.
Score: 0.097
-
Treatment of the insulin resistance syndrome. Endocr Pract. 2003 Sep-Oct; 9 Suppl 2:99-104.
Score: 0.053
-
CONSENSUS STATEMENT BY THE AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY ON THE COMPREHENSIVE TYPE 2 DIABETES MANAGEMENT ALGORITHM - 2018 EXECUTIVE SUMMARY. Endocr Pract. 2018 01; 24(1):91-120.
Score: 0.036